webinar register page

CQV strategies that increase speed-to-market for gene therapy
To successfully increase speed-to-market for gene therapies, having a defined CQV (Commissioning, Qualification, and Validation) strategy is critical to project success. In this webinar co-sponsored by Precision ADVANCE and Project Farma, our panel of industry experts discuss tips for delivering efficient, reliable, GMP-compliant facilities and processes specific to gene therapy.

Attendees will have the opportunity to learn:
-Key factors for assembling an experienced and flexible team
-The importance of process knowledge, including equipment and design
-Quality-by-design principles and GAMP guidelines
-About automation, emerging bioreactor, single-use, and disposable technologies
-How to optimize speed-to-market by applying innovative COTS strategies, vendor documentation, out of place commissioning, and more
-Tips for navigating the regulatory landscape

00:53:00

* Required information
Loading